Janet Woodcock

See the following -

A New Drug In The Age Of Antibiotic Resistance

Cari Romm | The Atlantic | January 7, 2015

Two alarming figures from a report released last month by the U.K. government: By 2050, antibiotic resistance will cost the world a projected 10 million lives and $8 trillion each year...

Read More »

TransCelerate Identifies Pharmacovigilance as an Operational Challenge in Need of Transformation

Press Release | TransCelerate BioPharma Inc. | March 29, 2017

TransCelerate BioPharma Inc. today announced that it has added Pharmacovigilance to its portfolio, establishing two new global initiatives: 1.) Interpretation of Pharmacovigilance Regulations and 2.) Value of Safety Information Data Sources. Both initiatives aim to create solutions that will reduce resource inefficiencies, enhance information exchange with global health authorities and improve patient safety to drive more value for patients...